Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Takeda presents clinical and preclinical data on TAK-875 in diabetes

Sep. 21, 2011

Takeda launches Liovel tablets in Japan

Sep. 20, 2011

FDA approves Prolia for new indications

Sep. 20, 2011

Taisho sodium/glucose cotransporter 2 inhibitor shows promise in patients with type 2 diabetes

Sep. 20, 2011

Preclinical and clinical data on migalastat made available

Sep. 20, 2011

Pronova BioPharma initiates first-in-human study of PRC-4016

Sep. 19, 2011

SMART-5 trial data reported for bazedoxifene/conjugated estrogens

Sep. 19, 2011

Karo Bio obtains clearance for phase III trial in HeFH

Sep. 19, 2011

Vivus reaches agreement with FDA on Qnexa NDA

Sep. 19, 2011

Catabasis Pharmaceuticals identifies new NF-kappa-B activation inhibitors

Sep. 19, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...